Rock Springs Capital Management LP Q1 2025 Filing
Filed May 15, 2025
Portfolio Value
$1.7T
Holdings
96
Report Date
Q1 2025
Filing Type
13F-HR
All Holdings (96 positions)
| Stock | Value |
|---|---|
ARGXARGENX SE | $104.0B |
LLYELI LILLY & CO | $93.7B |
2L9BLUEPRINT MEDICINES CORP | $89.2B |
MDGLMADRIGAL PHARMACEUTICALS INC | $55.2B |
UNHUNITEDHEALTH GROUP INC | $52.6B |
TVTXTRAVERE THERAPEUTICS INC | $52.3B |
ISRGINTUITIVE SURGICAL INC | $50.5B |
RAREULTRAGENYX PHARMACEUTICAL IN | $50.5B |
PENPENUMBRA INC | $45.7B |
RVMDREVOLUTION MEDICINES INC | $45.3B |
RYTMRHYTHM PHARMACEUTICALS INC | $44.2B |
MIRMMIRUM PHARMACEUTICALS INC | $42.9B |
MRUSMERUS N V | $41.3B |
IM8NINSMED INC | $39.4B |
ALNYALNYLAM PHARMACEUTICALS INC | $38.7B |
ASNDASCENDIS PHARMA A/S | $33.7B |
ZLABZAI LAB LTD | $32.7B |
XENEXENON PHARMACEUTICALS INC | $31.3B |
NBIXNEUROCRINE BIOSCIENCES INC | $30.9B |
NUVLNUVALENT INC | $30.3B |
AGLAGILON HEALTH INC | $30.1B |
PHRPHREESIA INC | $29.4B |
BSXBOSTON SCIENTIFIC CORP | $27.9B |
AKROAKERO THERAPEUTICS INC | $27.2B |
DC4DEXCOM INC | $27.2B |
IRTCIRHYTHM TECHNOLOGIES INC | $26.6B |
EVHEVOLENT HEALTH INC | $25.5B |
SRRKSCHOLAR ROCK HLDG CORP | $24.5B |
KYMRKYMERA THERAPEUTICS INC | $21.7B |
EXASEXACT SCIENCES CORP | $20.8B |
ACHCACADIA HEALTHCARE COMPANY IN | $20.7B |
GPCRSTRUCTURE THERAPEUTICS INC | $19.6B |
SMMTSUMMIT THERAPEUTICS INC | $19.2B |
EWEDWARDS LIFESCIENCES CORP | $18.5B |
TARSTARSUS PHARMACEUTICALS INC | $18.2B |
THCTENET HEALTHCARE CORP | $17.5B |
LEGNLEGEND BIOTECH CORP | $17.4B |
IMVTIMMUNOVANT INC | $16.7B |
AZTAAZENTA INC | $16.5B |
INSPINSPIRE MED SYS INC | $15.8B |
AM6AMICUS THERAPEUTICS INC | $15.6B |
WRBYWARBY PARKER INC | $15.2B |
MREOMEREO BIOPHARMA GROUP PLC | $15.0B |
TCE2CELLDEX THERAPEUTICS INC NEW | $14.7B |
OSCROSCAR HEALTH INC | $13.8B |
WSTWEST PHARMACEUTICAL SVSC INC | $13.5B |
VERAVERA THERAPEUTICS INC | $12.5B |
DHRDANAHER CORPORATION | $12.1B |
NAMSNEWAMSTERDAM PHARMA COMPANY | $11.0B |
SRPTSAREPTA THERAPEUTICS INC | $10.2B |
AGIOAGIOS PHARMACEUTICALS INC | $10.0B |
PHVSPHARVARIS N V | $9.8B |
CMPXCOMPASS THERAPEUTICS INC | $9.4B |
ELVNENLIVEN THERAPEUTICS INC | $9.2B |
SLNOSOLENO THERAPEUTICS INC | $8.9B |
ARDXARDELYX INC | $7.9B |
ACRSACLARIS THERAPEUTICS INC | $7.7B |
ZBIOZENAS BIOPHARMA INC | $6.9B |
ETNBGBP89BIO INC | $6.1B |
PRTAPROTHENA CORP PLC | $6.1B |
JANXJANUX THERAPEUTICS INC | $5.5B |
DYNDYNE THERAPEUTICS INC | $5.5B |
GOSS 5 06/01/27GOSSAMER BIO INC | $5.3B |
MLYSMINERALYS THERAPEUTICS INC | $5.1B |
CGEMCULLINAN THERAPEUTICS INC | $4.9B |
NVROEURNEVRO CORP | $4.7B |
BCAXBICARA THERAPEUTICS INC | $4.4B |
NVV1NOVAVAX INC | $4.2B |
KMTSKESTRA MED TECHNOLOGIES LTD | $3.6B |
GOSSGOSSAMER BIO INC | $3.6B |
LUNGPULMONX CORP | $3.4B |
INZYINOZYME PHARMA INC | $3.1B |
BEAMBEAM THERAPEUTICS INC | $2.9B |
ATECALPHATEC HLDGS INC | $2.7B |
SGMTSAGIMET BIOSCIENCES INC | $2.6B |
EDAEDAP TMS S A | $2.5B |
JSPRJASPER THERAPEUTICS INC | $2.3B |
LENZLENZ THERAPEUTICS INC | $2.1B |
REGNREGENERON PHARMACEUTICALS | $1.8B |
APLSAPELLIS PHARMACEUTICALS INC | $1.7B |
BCRXBIOCRYST PHARMACEUTICALS INC | $1.7B |
MGNXMACROGENICS INC | $1.5B |
CGENCOMPUGEN LTD | $1.4B |
—MERSANA THERAPEUTICS INC | $1.3B |
NGNENEUROGENE INC | $1.2B |
AMLXAMYLYX PHARMACEUTICALS INC | $1.2B |
SIONSIONNA THERAPEUTICS INC | $1.0B |
APLTAPPLIED THERAPEUTICS INC | $1.0B |
CATXPERSPECTIVE THERAPEUTICS INC | $946.5M |
VIGLVIGIL NEUROSCIENCE INC | $840.1M |
PLRXPLIANT THERAPEUTICS INC | $796.5M |
SPRBSPRUCE BIOSCIENCES INC | $756.9M |
KRROKORRO BIO INC | $621.9M |
ADAPYADAPTIMMUNE THERAPEUTICS PLC | $489.2M |
TLPHTALPHERA INC | $156.6M |
NUVB/WSNUVATION BIO INC | $32.0M |